Health technology
Continued advocacy for research collaboration, translation, and commercialisation for health technologies has the potential to transform Australia’s healthcare sector.
Continued advocacy for research collaboration, translation, and commercialisation for health technologies has the potential to transform Australia’s healthcare sector.
ATSE’s Health Technology Forum explores how technology is helping progress the healthcare sector towards a more sustainable and resilient future. The Forum contains experts in medical science, medical technologies, health governance and administration and medical manufacturing. The Forum is current working on projects relating to anti-microbial resistance, research translation and digital health technologies.
Through research and consultation with multi-disciplinary experts, this report has identified the key challenges and opportunities for Australia to improve prevention, detection, diagnosis, and response to drug-resistant infections and reduce the impacts of antimicrobial resistance.
Chair: Trevor Danos AM FTSE FAICD
Deputy Chairs: Professor Jan Tennent FTSE and Professor Sally McArthur FTSE
Australia has a notable opportunity in biotechnology, with ribonucleic acid (RNA) therapies and technologies primarily in the research phase, focusing on vaccines, protein therapies, cancer treatment and biopesticides.
Dr Elaine Saunders FTSE is an entrepreneur, businesswoman, author, inventor, a supporter of women in STEM, an advocate for Australian innovation and a trusted adviser on a range of advisory panels to government, industry and academia.
The reform offers Australia the opportunity to determine how health and medical research can better fit the nation’s needs now and into the future.